Canadian Cannabis LP
Tier 3 Index
The Canadian Cannabis LP Tier 3 Index represents the publicly-traded market for companies that have quarterly cannabis sales from LP activities between $2.5 million and $7.5 million.
The Canadian Cannabis LP Tier 3 index is equal-weighted at the time of the month-end rebalancing and includes includes members of the Canadian Cannabis LP Index with quarterly sales of cannabis between $2.5 million and $7.5 million. The index members are based on information that was available on 12/29/21. Until 11/30/21, the range was zero to $5 million, with companies needing to have a stock price of at least $0.20 a the time of rebalancing if the quarterly revenue was less than $2.5 million, a rule that changed on 6/30/20 after being implemented as of 12/31/19 at $1 million. The maximum revenue was increased from $2.5 million on 6/30/20. Before 12/31/18, the group included those LPs licensed by Health Canada to cultivate but not yet permitted to sell.
Inclusion in any index is not an endorsement or recommendation of any company. This Site is not an intermediary, broker/dealer, investment advisor, or exchange and does not provide investment advice or investment advisory services. QuoteMedia Data delayed 15 minutes unless otherwise indicated.